Global Single-Cell Genomics
Market Segmentation, By Product Type (Instruments {Single-cell Isolation &
Dispensing Systems, Polymerase Chain Reaction (PCR) Systems, Next-Generation
Sequencing (NGS) Platforms, Microarrays, High-Content Screening Systems}, Consumables
{Assay Kits & Reagents, Beads & Microplates}, Software & Services),
By Technology (Single-Cell RNA Sequencing (scRNA-seq), Single-Cell DNA
Sequencing (scDNA-seq), Single-Cell ATAC Sequencing (scATAC-seq), Single-Cell
Genome Sequencing, Single-Cell Transcriptomics, Flow Cytometry, Mass
Spectrometry (CyTOF)), By Workflow (Single-Cell Isolation & Capture, Sample
Preparation, Genomic Analysis, Data Analysis & Interpretation), By
Application (Oncology {Tumor Heterogeneity, Cancer Genomics}, Immunology, Neurology,
Stem Cell Research, Developmental Biology, Others), By End-User (Academic &
Research Institutes, Biotechnology & Pharmaceutical Companies, Hospitals
& Diagnostic Laboratories, Contract Research Organizations (CROs))-
Industry Trends and Forecast to 2033
Global Single-Cell Genomics
Market size was valued at USD 2042.7 million in 2024 and is expected to reach at
USD 10521.7 million in 2033, with a CAGR of 16.7% during the forecast period of
2025 to 2033.
Global Single-Cell Genomics Market Overview
The global Single-Cell Genomics
market is experiencing robust growth driven by advancements in next-generation
sequencing (NGS), microfluidics, and bioinformatics. This technology enables
detailed analysis of individual cells, providing crucial insights into cellular
diversity, disease mechanisms, and gene expression. Rising applications in
oncology, immunology, neurology, and precision medicine are accelerating
adoption. Increasing government and private funding for genomic research, along
with growing collaborations between biotech firms and research institutes, are
further boosting market expansion. However, high costs, data complexity, and
lack of standardization remain key challenges. Overall, the market continues to
evolve as single-cell technologies advance toward clinical utility.
Global Single-Cell Genomics Market Scope
|
Global Single-Cell
Genomics Market |
|||
|
Years
Considered |
|||
|
Historical Period |
2020 - 2023 |
Market Size (2024) |
USD 2042.7 Million |
|
Base Year |
2024 |
Market Size
(2033) |
USD 10521.7 Million |
|
Forecast Period |
2025 - 2033 |
CAGR (2025 – 2033) |
16.7% |
|
Segments
Covered |
|||
|
By Product Type |
·
Instruments o Single-cell
Isolation & Dispensing Systems o Polymerase
Chain Reaction (PCR) Systems o Next-Generation
Sequencing (NGS) Platforms o Microarrays o High-Content
Screening Systems ·
Consumables o Assay
Kits & Reagents o Beads
& Microplates ·
Software & Services |
||
|
By Technology |
·
Single-Cell
RNA Sequencing (scRNA-seq) ·
Single-Cell
DNA Sequencing (scDNA-seq) ·
Single-Cell
ATAC Sequencing (scATAC-seq) ·
Single-Cell
Genome Sequencing ·
Single-Cell
Transcriptomics ·
Flow
Cytometry ·
Mass
Spectrometry (CyTOF |
||
|
By Work Flow |
·
Single-Cell Isolation & Capture ·
Sample Preparation ·
Genomic Analysis ·
Data Analysis & Interpretation |
||
|
By Application |
·
Oncology o Tumor Heterogeneity o Cancer Genomics ·
Immunology ·
Neurology ·
Stem
Cell Research ·
Developmental
Biology ·
Others |
||
|
By End Users |
·
Academic & Research Institutes ·
Biotechnology & Pharmaceutical Companies ·
Hospitals & Diagnostic Laboratories ·
Contract Research Organizations (CROs) |
||
|
Countries
Catered |
|||
|
North America |
·
United States ·
Canada ·
Mexico |
||
|
Europe |
·
United
Kingdom ·
Germany ·
France ·
Spain ·
Italy ·
Rest
of Europe |
||
|
Asia Pacific |
·
China ·
India ·
Japan ·
Australia ·
South Korea ·
Rest of Asia Pacific |
||
|
Latin America |
·
Brazil ·
Argentina ·
Rest
of Latin America |
||
|
Middle East & Africa
|
·
Saudi Arabia ·
South Africa ·
Rest of MEA |
||
|
Key Companies |
|||
|
·
Thermo Fisher Scientific Inc. ·
NanoString Technologies, Inc. |
|||
Global Single-Cell Genomics Market Dynamics
The global Single-Cell Genomics
market dynamics are shaped by rapid technological advancements, growing
research applications, and increasing demand for personalized medicine. Key
drivers include the expanding use of single-cell sequencing in cancer research,
stem cell biology, immunology, and infectious disease studies. The technology
enables high-resolution cellular profiling, helping researchers uncover genetic
heterogeneity and disease progression at an unprecedented level. The
integration of artificial intelligence (AI), bioinformatics, and microfluidics
has further enhanced data analysis accuracy, scalability, and throughput.
Additionally, rising investments from governments, research institutions, and
biopharmaceutical companies are fueling innovation and infrastructure
development in genomics research.
However, the market faces
challenges such as high instrument and reagent costs, complex data
interpretation, and the need for specialized computational tools and skilled
professionals. Ethical and data privacy concerns also restrict large-scale
adoption in clinical applications. Nonetheless, emerging trends like spatial
genomics, single-cell multi-omics integration, and automation in sample
processing are creating significant growth opportunities. Furthermore, the
rising focus on precision medicine and biomarker discovery is expected to drive
widespread adoption across healthcare and diagnostics. Overall, the market is
poised for sustained growth, supported by continuous innovation, collaborative
research initiatives, and the expanding scope of genomic applications across
clinical and translational research.
Global Single-Cell Genomics
Market Segment Analysis
The global Single-Cell Genomics
market segment analysis reveals a comprehensive landscape shaped by diverse
technologies, applications, and end-users driving innovation and adoption. By
product type, the market is categorized into instruments, consumables, and
software & services. Instruments, including single-cell isolation and
dispensing systems, PCR systems, next-generation sequencing (NGS) platforms,
microarrays, and high-content screening systems, dominate due to their critical
role in enabling high-throughput and precise cellular analysis. Consumables
such as assay kits, reagents, beads, and microplates are witnessing increasing
demand driven by frequent usage in sequencing and analytical workflows.
Meanwhile, software and bioinformatics services are expanding rapidly,
addressing the growing need for efficient data analysis, visualization, and
interpretation of single-cell datasets.
By technology, the market
includes single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing
(scDNA-seq), single-cell ATAC sequencing (scATAC-seq), single-cell genome
sequencing, single-cell transcriptomics, flow cytometry, and mass spectrometry
(CyTOF). Among these, scRNA-seq holds the largest share, enabling in-depth
analysis of cellular gene expression and heterogeneity. The integration of
multi-omics technologies is also transforming biological discovery and disease
profiling.
By workflow, the market
encompasses single-cell isolation & capture, sample preparation, genomic
analysis, and data analysis & interpretation. Single-cell isolation and
genomic analysis are key stages, driven by innovations in microfluidics and sequencing
chemistry.
By application, the market serves
areas such as oncology, immunology, neurology, stem cell research, and
developmental biology. Oncology dominates due to applications in tumor
heterogeneity and cancer genomics, while immunology and stem cell research are
rapidly growing segments supporting drug discovery and regenerative medicine.
By end-user, the market is
segmented into academic & research institutes, biotechnology &
pharmaceutical companies, hospitals & diagnostic laboratories, and contract
research organizations (CROs). Academic institutions lead in research adoption,
while pharmaceutical companies increasingly use single-cell technologies for
biomarker discovery, drug target validation, and precision medicine
development. Overall, growing cross-sector collaboration, technological
integration, and clinical translational research continue to propel the
market’s global expansion.
Global Single-Cell Genomics
Market Regional Analysis
The global Single-Cell Genomics
market regional analysis highlights North America as the dominant region,
driven by advanced research infrastructure, strong funding for genomics
projects, and the presence of major biotechnology and sequencing companies. The
U.S. leads in adoption due to its extensive focus on cancer genomics,
immunology, and precision medicine initiatives. Europe follows closely,
supported by government-funded genomic programs and academic–industry
collaborations across countries such as the U.K., Germany, and France.
Asia-Pacific is projected to register the fastest growth, fueled by rising
investments in biotechnology, expanding genomic research in China, Japan, and
India, and the growing implementation of single-cell sequencing in clinical
studies. Meanwhile, Latin America and the Middle East & Africa are emerging
markets, gradually adopting single-cell technologies for healthcare and
biomedical research. Increasing collaborations, declining sequencing costs, and
technological advancements across these regions continue to strengthen the
global single-cell genomics ecosystem.
Global Single-Cell Genomics Market Key Players
·
10x Genomics
·
Illumina, Inc.
·
Fluidigm Corporation
·
Bio-Rad Laboratories, Inc.
·
Thermo Fisher Scientific Inc.
·
BGI Genomics Co., Ltd.
·
Takara Bio, Inc.
·
NanoString Technologies, Inc.
·
QIAGEN N.V.
·
Oxford Nanopore Technologies
·
PerkinElmer, Inc.
·
Roche Sequencing Solutions
Recent Developments
On July 9, 2024, Illumina,
Inc. announced the acquisition of Fluent BioSciences, a move aimed at
enhancing its position in the rapidly expanding single-cell genomics market.
This acquisition strengthens Illumina’s single-cell analysis capabilities and
supports its strategic vision to make multi-omics workflows more accessible to
researchers and clinical users. Fluent BioSciences is known for its innovative
instrument-free single-cell analysis technology, which simplifies sample
preparation and reduces the cost and complexity associated with single-cell
sequencing.
On November 6, 2024, CS
Genetics launched its groundbreaking “SimpleCell™ 3′ Gene Expression Kits,”
marking a major advancement in the field of single-cell transcriptomics. This
innovative solution eliminates the need for complex instrumentation, making
single-cell analysis more accessible, cost-effective, and scalable for
laboratories of all sizes. The SimpleCell platform enables researchers to
perform single-cell RNA sequencing (scRNA-seq) workflows with simplified setup
and reduced technical barriers, allowing for high-throughput gene expression
profiling across diverse cell types.
Research Methodology
At Foreclaro Global Research, our
research methodology is firmly rooted in a comprehensive and systematic
approach to market research. We leverage a blend of reliable public and
proprietary data sources, including industry reports, government publications,
company filings, trade journals, investor presentations, and credible online
databases. Our analysts critically evaluate and triangulate information to
ensure accuracy, consistency, and depth of insights. We follow a top-down and
bottom-up data modelling framework to estimate market sizes and forecasts,
supplemented by competitive benchmarking and trend analysis. Each research
output is tailored to client needs, backed by transparent data validation
practices, and continuously refined to reflect dynamic market conditions.
The global single-cell genomics market was valued at USD 2,042.7 million in 2024 and is projected to reach USD 10,521.7 million by 2033, growing at a CAGR of around 16.7% from 2025 to 2033.
